Jitter and muscle fiber conduction velocity in long COVID fatigue

João Aris Kouyoumdjian; Leticia Akemi Rama Yamamoto; Carla Renata Graca

doi:10.1055/s-0045-1802961

Arquivos de Neuro-Psiquiatria, Table of Contents

CC BY 4.0 · Arq Neuropsiquiatr 2025; 83(01): s00451802961
DOI: 10.1055/s-0045-1802961

Original Article

Jitter and muscle fiber conduction velocity in long COVID fatigue

Authors

João Aris Kouyoumdjian

¹Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), Departamento de Ciências Neurológicas, Psiquiatria e Psicologia Médica, Laboratório de Investigação Neuromuscular, São José do Rio Preto SP, Brazil.
Leticia Akemi Rama Yamamoto

¹Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), Departamento de Ciências Neurológicas, Psiquiatria e Psicologia Médica, Laboratório de Investigação Neuromuscular, São José do Rio Preto SP, Brazil.
Carla Renata Graca

¹Faculdade Estadual de Medicina de São José do Rio Preto (FAMERP), Departamento de Ciências Neurológicas, Psiquiatria e Psicologia Médica, Laboratório de Investigação Neuromuscular, São José do Rio Preto SP, Brazil.

Abstract

Background Long coronavirus disease (long COVID, LC) is defined as the continuation or development of new symptoms 3 months after the acute stage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In LC, the rate of fatigue/postexertional malaise (F-PEM) has been described to be as high as 70%, regardless of age or severity of the acute symptoms.

Objective To evaluate the neuromuscular junction (NMJ) function and the isolated muscle fiber conduction velocity (MFCV) in situ in LC cases and controls.

Methods We studied 37 subjects without SARS-CoV-2 (controls) and 32 cases of SARS-CoV-2 infection, half with LC symptoms (LC-yes) and half without them (LC-no). Single-fiber electromyography (jitter measured with a concentric electrode), MFCV, the fast-to-slow MFCV ratio (F/S ratio), and the motor unit potentials (MUPs) were taken in the tibialis anterior muscle.

Results At least 1 jitter parameter was abnormal in 1/37 controls, in 1/16 LC-no patients, and in 2/16 LC-yes patients, without significant differences among them. None of the subjects with abnormal jitter presented fluctuation symptoms or positive acetylcholine-receptor antibody. The MFCV and F/S ratios did not show abnormalities in any of the participants. The MUPs did not show myopathic or neurogenic abnormality in needle electromyography. The most frequent symptom in LC was F-PEM, which occurred in all LC-yes patients and was significantly different from the other groups.

Conclusion Fatigue/postexertional malaise was found in all cases of LC, and the electrophysiological findings did not indicate the muscle fiber or the NMJ as a relevant factor in this condition.

Keywords

SARS-CoV-2 - Post-Acute COVID-19 Syndrome - Fatigue - Single-Fiber Electromyography - Muscle Fiber Conduction Velocity

Bibliographical Record
João Aris Kouyoumdjian, Leticia Akemi Rama Yamamoto, Carla Renata Graca. Jitter and muscle fiber conduction velocity in long COVID fatigue. Arq Neuropsiquiatr 2025; 83: s00451802961.
DOI: 10.1055/s-0045-1802961

Full Text

References

References
1 Zhu N, Zhang D, Wang W. et al; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
2 World Health Organization. Coronavirus (COVID-19) Dashboard, site https://covid19.who.int/, searched on June 17, 2024.
3 Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21 (03) 133-146
4 World Health Organization - Post COVID-19 condition (Long COVID) - https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition# , December 2022.
5 Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021; 53 (10) 737-754
6 Hejbøl EK, Harbo T, Agergaard J. et al. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur J Neurol 2022; 29 (09) 2832-2841
7 Mahmud R, Rahman MM, Rassel MA. et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One 2021; 16 (04) e0249644
8 Sanchez-Ramirez DC, Normand K, Zhaoyun Y, Torres-Castro R. Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-Analysis. Biomedicines 2021; 9 (08) 900
9 Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11 (01) 16144
10 Baker AME, Maffitt NJ, Del Vecchio A. et al. Neural dysregulation in post-COVID fatigue. Brain Commun 2023; 5 (03) fcad122
11 Huang C, Huang L, Wang Y. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397 (10270): 220-232
12 Stålberg EV, Trontelj JV, Sanders DB. Single Fiber EMG. 3rd ed.. Fiskebäckskil, Sweden: Edshagen Publishing House; 2010
13 Stålberg E. Propagation velocity in human muscle fibers in situ. Acta Physiol Scand Suppl 1966; 287: 1-112
14 Kouyoumdjian JA, Graca CR. Concentric needle jitter: Reference values in stimulated Tibialis Anterior muscle. Front Neurol 2022; 13: 957174
15 Sanders DB, Arimura K, Cui L. et al. Guidelines for single fiber EMG. Clin Neurophysiol 2019; 130 (08) 1417-1439
16 Kouyoumdjian JA, Graca CR. Muscle fiber conduction velocity in situ revisited: A new approach to an ancient technique. Front Neurol 2023; 14: 1118510
17 Sanders DB, Kouyoumdjian JA, Stålberg EV. Single fiber electromyography and measuring jitter with concentric needle electrodes. Muscle Nerve 2022; 66 (02) 118-130
18 Ceban F, Ling S, Lui LMW. et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 2022; 101: 93-135
19 Halpin SJ, McIvor C, Whyatt G. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021; 93 (02) 1013-1022
20 Arnold DT, Hamilton FW, Milne A. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021; 76 (04) 399-401
21 Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022; 28 (07) 1461-1467
22 Blomberg B, Mohn KG, Brokstad KA. et al; Bergen COVID-19 Research Group. Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021; 27 (09) 1607-1613
23 Alkodaymi MS, Omrani OA, Fawzy NA. et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect 2022; 28 (05) 657-666
24 Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) 2021; 8: 653516
25 Rochmawati E, Iskandar AC, Kamilah F. Persistent symptoms among post-COVID-19 survivors: A systematic review and meta-analysis. J Clin Nurs 2022; •••
26 Angarita-Fonseca A, Torres-Castro R, Benavides-Cordoba V. et al. Exploring long COVID condition in Latin America: Its impact on patients' activities and associated healthcare use. Front Med (Lausanne) 2023; 10: 1168628
27 Buttery S, Philip KEJ, Williams P. et al. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res 2021; 8 (01) e001075
28 Davis HE, Assaf GS, McCorkell L. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019
29 Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr 2021; 15 (03) 869-875
30 Nalbandian A, Sehgal K, Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27 (04) 601-615
31 Townsend L, Dyer AH, Jones K. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 2020; 15 (11) e0240784
32 Abrams RMC, Zhou L, Shin SC. Persistent post-COVID-19 neuromuscular symptoms. Muscle Nerve 2023; 68 (04) 350-355
33 Suh J, Amato AA. Neuromuscular complications of coronavirus disease-19. Curr Opin Neurol 2021; 34 (05) 669-674
34 Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324 (06) 603-605
35 Scordo KA, Richmond MM, Munro N. Post-COVID-19 Syndrome: Theoretical Basis, Identification, and Management. AACN Adv Crit Care 2021; 32 (02) 188-194
36 Elanwar R, Hussein M, Magdy R. et al. Physical and Mental Fatigue in Subjects Recovered from COVID-19 Infection: A Case-Control Study. Neuropsychiatr Dis Treat 2021; 17: 2063-2071
37 Adams and Victor's Principles of Neurology. Ropper AH, Samuels MA, Klein JP, Prasad S. eds. 20th ed.. New York: McGraw Hill LLC; 2023
38 Tankisi H, Versace V, Kuppuswamy A, Cole J. The role of clinical neurophysiology in the definition and assessment of fatigue and fatigability. Clin Neurophysiol Pract 2023; 9: 39-50
39 Agergaard J, Leth S, Pedersen TH. et al. Myopathic changes in patients with long-term fatigue after COVID-19. Clin Neurophysiol 2021; 132 (08) 1974-1981
40 Agergaard J, Yamin Ali Khan B, Engell-Sørensen T. et al; MULTICOV Consortium. Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology. Clin Neurophysiol 2023; 148: 65-75